ClinicalTrials.gg
CompletedNCT02642835Updated May 29, 2018Results posted

A Long Term Follow up of Anterior Meshes for Recurrent Prolapse

An observational study in Genital Diseases, Female and Pelvic Organ Prolapse, sponsored by Medway NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to female participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2018-05-29.

Sponsored by Medway NHS Foundation Trust · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
48
Ages
18 Years to 100 Years
Sex
Female
01

Study summary

Prolapse of the vaginal wall and uterus are common conditions affecting up to 50% of parous women. The socioeconomic, psychological and physical impacts of prolapse are considerable. 11% of women will undergo a surgical repair by the age of 80 years. The commonest compartment affected is the anterior vaginal wall. Unfortunately there is a significant rate of recurrent prolapse or a failure of the primary procedure. This has lead to the introduction of new techniques and the use of different materials to augment the repair. Mesh augmented repairs aim to reduce the rate of recurrent prolapse. However, the use of synthetic mesh is associated with complications which are not found in non mesh repairs. 10% of women will have a mesh complication of which 70% will require a further surgical procedure to manage the complication. There are extra costs associated with purchasing the mesh, with longer operating times to insert the mesh and managing complications caused by the mesh. Balancing the extra risks of mesh surgery against the benefits is probably one of the most contentious issues in urogynaecology at the present time.

Regulatory authorities in the USA (FDA) and UK (MHRA) have become increasingly interested in the use of mesh to support the vaginal wall in prolapse surgery due to risks and complications being reported. To date there is little evidence regarding the long term safety and efficacy of anterior mesh repairs. This study aims to rectify this deficiency for Perigee.

Read the detailed description

This will be a consecutive cohort study of patients identified from a surgical database of Perigees performed in a single centre. All patients will have had the procedure performed between 2007 and 2011. This will be a single centre study. The principle investigator has both electronic and hand written records of all Perigee repairs performed since the introduction of this technique in 2007. The patients will be identified from both the paper and electronic databases and cross referenced.

After obtained appropriate ethical approval, patients identified as having a perigee mesh inserted will be asked to attend Medway Hospital for a full clinical evaluation. They will be sent a letter with an appointment to come to the hospital. They will be asked to complete the Pelvic floor distress inventory questionnaire to assess their symptoms. They will have a pelvic examination to determine if they have any mesh erosion and will undergo a POP-Q score. This visit will take 1 hour.

02

Conditions studied

  • Genital Diseases, Female
  • Pelvic Organ Prolapse

Keywords

  • mesh
  • pelvic organ prolapse
03

In context

Genital Diseases, Female

161 studies on the registry are indexed under Genital Diseases, Female; 31 are open to participants now.

This study's enrollment of 48 is below the median of 200 across 37 observational studies indexed under Genital Diseases, Female.

Browse Genital Diseases, Female studies →

Lead sponsor

Medway NHS Foundation Trust is the lead sponsor of 13 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Consecutive patients having previously undergone a mesh repair

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women undergoing a perigee procedure after January 2007

Exclusion criteria

Exclusion Criteria:

  • Patient having non mesh repairs over the same time scale
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
48 participants (actual)
Patient registry
No

Interventions

  • Procedurevaginal wall mesh

    retrospective review of case series

06

What researchers measure

Primary outcomes

  1. The Number of Participants With a Current Mesh Erosion or Treated for a Mesh Erosion Since Inserted

    clinic visit. 5 patients were interviewed by phone and were not examined - hence this figure is out of 43 not 48.

    Time frame: 1 hour

Secondary outcomes

  1. Number of Participants With no Physical Evidence of Recurrent Prolapse as Determined by Physical Examination

    The presence of less than stage 2 prolapse (eg stage 1) anterior wall prolapse determined as anatomical success. A stage one prolapse is higher than 1cm above the vaginal entrance. A stage 2 prolapse means that the leading edge of the prolapse is between 1cm above the entrance to the vagina up to 1cm below the entrance to the vagina.

    Time frame: 1 hour

  2. Number of Participants Complaining of a Bulge. Recurrent Prolapse

    Efficacy determined by the question in the pelvic floor prolapse distress inventory "usually have a bulge or something falling out that you can see or feel in your vaginal area". Determined at clinic visit by questioning

    Time frame: 1 hour

  3. Number of Participants Requiring Treatment for Recurrent Prolapse - Prolapse in the Same Part of the Vagina

    clinic visit; number of participants who underwent reoperation of recurrent prolapse in the same compartment

    Time frame: 1 hour

  4. Number of Participants Who Underwent Reoperation for Prolapse in a Different Compartment

    This is where the mesh has held up and there is no prolapse where it was inserted. This measure refers to when a different part of the vagina has prolapsed.

    Time frame: 1 hour

  5. Number of Participants Who Developed New Stress Incontinence

    The mesh has caused the prolapse to be successfully repaired but the patient has developed stress incontinence as a separate issue. clinic visit

    Time frame: 1 hour

  6. Number of Participants Who Rated Their Improvement as Better or Very Much Better

    The patient global impression of Improvement scale (PGI-I) is a global improvement scale filled out by the patient. It is graded as very much better, much better, a little better. no change, a little worse, much worse or very much worse.clinic visit

    Time frame: 1 hour

  7. Number of Participants Who Needed Surgical Mesh Removal for Erosion

    A mesh erosion is when the body rejects the mesh and it is visible in the vagina rather than being buried under the vaginal epithelium. clinic visit

    Time frame: 1 hour

  8. Number of Participants Who Needed Reoperations for Pain

    patients may develop pain after the original operation which needs a second surgical procedure to try and help. clinic visit

    Time frame: 1 hour

  9. Number of Participants Who Experienced Intraoperative Complications

    This records any problems that were encountered at the original insertion of the mesh. clinic visit

    Time frame: 1 hour

07

Results

Posted May 29, 2018

Participant flow

Participant flow — Overall Study
MilestoneMesh Group
Started48
Completed48
Not completed0

Outcome measures

PrimaryThe Number of Participants With a Current Mesh Erosion or Treated for a Mesh Erosion Since Inserted

clinic visit. 5 patients were interviewed by phone and were not examined - hence this figure is out of 43 not 48.

Time frame:
1 hour
Reported as:
Count of participants · Participants
The Number of Participants With a Current Mesh Erosion or Treated for a Mesh Erosion Since Inserted
ParticipantsMesh Group
The Number of Participants With a Current Mesh Erosion or Treated for a Mesh Erosion Since Inserted5
SecondaryNumber of Participants With no Physical Evidence of Recurrent Prolapse as Determined by Physical Examination

The presence of less than stage 2 prolapse (eg stage 1) anterior wall prolapse determined as anatomical success. A stage one prolapse is higher than 1cm above the vaginal entrance. A stage 2 prolapse means that the leading edge of the prolapse is between 1cm above the entrance to the vagina up to 1cm below the entrance to the vagina.

Time frame:
1 hour
Reported as:
Count of participants · Participants
Number of Participants With no Physical Evidence of Recurrent Prolapse as Determined by Physical Examination
ParticipantsMesh Group
Number of Participants With no Physical Evidence of Recurrent Prolapse as Determined by Physical Examination26
SecondaryNumber of Participants Complaining of a Bulge. Recurrent Prolapse

Efficacy determined by the question in the pelvic floor prolapse distress inventory "usually have a bulge or something falling out that you can see or feel in your vaginal area". Determined at clinic visit by questioning

Time frame:
1 hour
Reported as:
Count of participants · Participants
Number of Participants Complaining of a Bulge. Recurrent Prolapse
ParticipantsMesh Group
Number of Participants Complaining of a Bulge. Recurrent Prolapse14
SecondaryNumber of Participants Requiring Treatment for Recurrent Prolapse - Prolapse in the Same Part of the Vagina

clinic visit; number of participants who underwent reoperation of recurrent prolapse in the same compartment

Time frame:
1 hour
Reported as:
Count of participants · Participants
Number of Participants Requiring Treatment for Recurrent Prolapse - Prolapse in the Same Part of the Vagina
ParticipantsMesh Group
Number of Participants Requiring Treatment for Recurrent Prolapse - Prolapse in the Same Part of the Vagina1
SecondaryNumber of Participants Who Underwent Reoperation for Prolapse in a Different Compartment

This is where the mesh has held up and there is no prolapse where it was inserted. This measure refers to when a different part of the vagina has prolapsed.

Time frame:
1 hour
Reported as:
Count of participants · Participants
Number of Participants Who Underwent Reoperation for Prolapse in a Different Compartment
ParticipantsMesh Group
Number of Participants Who Underwent Reoperation for Prolapse in a Different Compartment8
SecondaryNumber of Participants Who Developed New Stress Incontinence

The mesh has caused the prolapse to be successfully repaired but the patient has developed stress incontinence as a separate issue. clinic visit

Time frame:
1 hour
Reported as:
Count of participants · Participants
Number of Participants Who Developed New Stress Incontinence
ParticipantsMesh Group
Number of Participants Who Developed New Stress Incontinence5
SecondaryNumber of Participants Who Rated Their Improvement as Better or Very Much Better

The patient global impression of Improvement scale (PGI-I) is a global improvement scale filled out by the patient. It is graded as very much better, much better, a little better. no change, a little worse, much worse or very much worse.clinic visit

Time frame:
1 hour
Reported as:
Count of participants · Participants
Number of Participants Who Rated Their Improvement as Better or Very Much Better
ParticipantsMesh Group
Number of Participants Who Rated Their Improvement as Better or Very Much Better33
SecondaryNumber of Participants Who Needed Surgical Mesh Removal for Erosion

A mesh erosion is when the body rejects the mesh and it is visible in the vagina rather than being buried under the vaginal epithelium. clinic visit

Time frame:
1 hour
Reported as:
Count of participants · Participants
Number of Participants Who Needed Surgical Mesh Removal for Erosion
ParticipantsMesh Group
Number of Participants Who Needed Surgical Mesh Removal for Erosion2
SecondaryNumber of Participants Who Needed Reoperations for Pain

patients may develop pain after the original operation which needs a second surgical procedure to try and help. clinic visit

Time frame:
1 hour
Reported as:
Count of participants · Participants
Number of Participants Who Needed Reoperations for Pain
ParticipantsMesh Group
Number of Participants Who Needed Reoperations for Pain3
SecondaryNumber of Participants Who Experienced Intraoperative Complications

This records any problems that were encountered at the original insertion of the mesh. clinic visit

Time frame:
1 hour
Reported as:
Count of participants · Participants
Number of Participants Who Experienced Intraoperative Complications
ParticipantsMesh Group
Number of Participants Who Experienced Intraoperative Complications0

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Mesh Group0/48 (0%)0/48 (0%)0/48 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Mesh Group
Mean66 (47 to 83)
Sex: Female, Male
Sex: Female, Male(Participants)Mesh Group
Female48
Male0
BMI
BMI(wt kg/ht m squared)Mesh Group
Mean27.4 (19 to 44)
Parity
Parity(vaginal deliveries past 28 weeks)Mesh Group
Median2 (1 to 4)
time to follow up (months)
time to follow up (months)(number of months)Mesh Group
Mean82 (48 to 106)
08

Study locations

1 site
  • Medway NHS Foundation trust
    Gillingham, Kent ME5 7NY, United Kingdom
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Aug 2015, a primary completion of Mar 2016 and a completion of Mar 2016. It does not say whether these dates are actual or estimated.

Results were first posted in May 2018, 2 years 2 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 27, 2015
First posted
Dec 30, 2015
Start
Aug 2015
Primary completionActual
Mar 2016
CompletionActual
Mar 2016
Results first posted
May 29, 2018
Last update
May 29, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 29, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02642835
Lead sponsor
Medway NHS Foundation Trust
Responsible party
Professor Jonathan Duckett (Consultant Urogynaecologist, Medway NHS Foundation Trust) — Principal investigator
First posted
Dec 30, 2015
Start date
Aug 2015
Primary completion
Mar 2016
Completion
Mar 2016
Results posted
May 29, 2018
Last update
May 29, 2018

Study contacts

Jonathan Duckett, FRCOG
principal investigator · Medway NHS Foundation Trust

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion